FibroBiologics, Inc. (Nasdaq: FBLG) ('FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

ORLANDO, FL / ACCESS Newswire / July 11, 2025 / RedChip Companies will air interviews with Brag House Holdings, Inc.

This new article publication from Acta Pharmaceutica Sinica B, discusses a high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal ...

Fibroblasts reprogrammed into AT2-like lung cells in just 7–10 days, offering a faster, safer alternative to stem cell ...

The four-year-old biotech raised about $75 million in a Series A round that involved nine venture capital firms.

Thymagen peptide has garnered attention within scientific circles due to its hypothesized impact on various biological ...

FibroBiologics, Inc. (Nasdaq: FBLG) ('FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

ORLANDO, FL / ACCESS Newswire / July 11, 2025 / RedChip Companies will air interviews with Brag House Holdings, Inc. (NASDAQ:TBH) and FibroBiologics, Inc. (NASDAQ:FBLG) on the RedChip Small Stocks, Bi ...

Thermage FLX heats the deepest layer of the skin to around 140°F to stimulate the fibroblast to increase collagen production.

A new player in radioligand therapies (RLTs), Norway and US-based Actithera, has arrived on the scene with $75.5 million in ...

Researchers at Baylor College of Medicine found that psilocybin improved cell longevity and boosted survival in aged mice.

A new Hydrogel-Based Platform to preserve live patient-derived tumour tissues in the lab could pave the way for faster, more ...